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Measuring the glomerular filtration rate (GFR) by iohexol
plasma disappearance in children requires optimization of
duration and sampling times since shortening the study may
overestimate GFR. To determine these parameters, we
analyzed iohexol plasma disappearance curves using
multiple sampling points in each of 27 children in the
Chronic Kidney Disease in Children (CKiD) study. The GFR
measured after 5 h was comparable to that after 6 h, but
shortening to 4h resulted in a significant 3% overestimation
of GFR. We also sought to reduce the number of blood
samples to determine GFR. This was done by adapting the
Brochner-Mortensen equations to derive the relationship
between a single-compartment two-sample (slow GFR
model) disappearance curve and that from a double
exponential analysis (two-compartment four-sample model)
in the first clinic visit of 489 children. Using polynomial
regression methods, we developed coefficients to accurately
measure GFR from a single-compartment model.
These coefficients were employed to recalculate the GFR
and compare these to values measured with the
two-compartment four-sample model in 361 of these
children in their second clinic visit. There was excellent
correlation (r¼ 0.999) and no bias or change in
between-individuals’ dispersion. Hence, the GFR can be
accurately measured in children with chronic kidney
disease using the slow component of the iohexol plasma
disappearance curve, provided the duration of study is
at least 5 h.
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Glomerular filtration rate (GFR) can accurately be deter-
mined from the plasma disappearance of iohexol after a
single bolus injection.1,2 The mathematical model for the
disappearance curve is an open two-compartment system.
The GFR marker is injected in the first compartment,
equilibrates with the second compartment, and is excreted
from the first compartment by glomerular filtration. Initially,
the concentration falls rapidly but at a progressively
diminishing rate, as there is diffusion of the marker in its
distribution volume in addition to renal excretion. There-
after, the slope of the decline of plasma concentration reflects
predominately its renal excretion rate. This latter decrease
occurs at the same exponential rate in the compartments
wherein it is distributed.
To perform epidemiological studies in chronic kidney
disease (CKD) cohorts, and encourage large-scale recruit-
ment, it is imperative that the duration of time spent at the
clinic or clinical research center not be excessive and
protocols be minimally intrusive. Although optimal GFR
studies may need to be performed overnight to obtain
maximal precision and accuracy of the measurements, such a
time commitment would compromise recruitment and
retention of subjects. Clearly, a proper balance between
accuracy and subject acceptance is necessary for designing
feasible kidney disease studies.
To obtain an accurate iohexol plasma disappearance curve,
several blood samples are required. Characterizing the curve
based only on samples from early time points will result in an
overestimation of the GFR.3 The first objective of this report
was to compare the GFR values based on time points of up to
4, 5, and 6 h using data on 27 children with sampling at 10,
20, 30, 60, 120, 180, 240, 300, and 360min.
The NIH-funded North American cohort study of
children with chronic kidney disease (CKiD) has used the
plasma disappearance of iohexol to generate a four-point
GFR (iGFR or GFR4, with sampling at 10, 30, 120, and
300min).4 To further simplify the iohexol protocol for
subjects and study personnel, we have considered condensing
the measurement to two sampling points at 120 and 300min.
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As described by Brochner–Mortensen,5 this is facilitated by
the tight relationship between the GFR obtained using multi-
compartment 51Cr-EDTA plasma disappearance curves (that
is, area under the full disappearance curve) and the GFR
obtained based only on a one-compartment (renal curve)
model corresponding to the slow rate of decline (that is, area
under the slow curve) to which hereafter we referred as the
slowGFR, a similar relationship has not been generated in
children using iohexol. In our pilot study,6 the relationship
between the 9-point iohexol plasma disappearance GFR and
the one-compartment GFR followed a similar quadratic
equation but there were too few subjects to generate a
relationship to three significant figures. However, the CKiD
study has collected enough data with four time points for us
to examine the relationship between iohexol disappearance
GFR based on four time points and the GFR based on two-
time points. Accordingly, the second aim of this report was to
evaluate whether a Brochner–Mortensen like equation
calibrated to the CKiD study accurately measures GFR and
obviates early blood sampling.
RESULTS
Table 1 provides the descriptive statistics of the pilot study
(n¼ 27) as well as those of the CKiD study with complete
data for the analysis at baseline (N¼ 489 of the 570 enrolled
before February 2009) and for the subcohort which has
completed the first follow up visit (N¼ 362). The profile of
the subset of 489 in this analysis from the 570 enrolled (see
Materials and Methods section) were very similar.
Duration of GFR study
Figure 1 shows the three GFR estimates for each of the 27
children in the original pilot study4 joined by a line and
according to the sampling interval. Shortening the sampling
interval of the slow (renal) curve from 6 to 5 h did not
significantly alter the measurement of GFR in the 27 subjects.
However, shortening to 4 h slightly but significantly increased
the measured GFR compared with 6 h. Indeed the median
GFR (Table 2) at 6 h was 51.3ml/min per 1.73m2, and the
median ratio of GFRs based on 5 h sampling compared with
that based on 6 h was 1.010 with an interquartile range (IQR)
of 0.995 to 1.021. At 4 h the median ratio was 1.030 with IQR
of 1.005–1.043 and the P-value for testing whether the ratio
different from one was less than 0.01. That is, there was a
significant 3% overestimation if sampling was truncated at
4 h after iohexol injection.
Examination of the plasma disappearance parameters in
Table 2 shows that except for the area under the slow curve,
all other parameters of the 4 h study were significantly
(Po0.05) different from those of the 6 h study. In contrast,
the only parameter of the 5 h study which was significantly
different (0.01oPo0.05) from those of the 6 h study was the
intercept of the fast curve, but it was only 1.7% lower. It
should be noted that the departures from one of the ratios of
the descriptors of the fast component are entirely because of
the variability of the coefficients of the slow component,
the data from which are subtracted from the observed
concentrations at 10 and 30min to determine the parameters
of the fast component.
Determining GFR from slow component of disappearance
curve
To derive a Brochner–Mortensen-like equation for subse-
quent use by the CKiD study, we examined the GFR
calculated from the slow component of the double exponen-
tial curve against that determined from the slow and fast
(double exponential) components. As expected, in 489
successful four-point GFR studies (Figure 2), the GFR
calculated from the slow component alone (slowGFR)
consistently overestimated that from the double exponential
GFR, which was calculated from the fast and slow
components. Using least square methods for a polynomial
regression with no intercept, we found that GFR could be
determined from the slow component (slowGFR) according
to the equation:
GFR ¼ 1:0019slowGFR 0:001258slowGFR2;
with R2¼ 99.9%.
These coefficients compare favorably with those pub-
lished by Brochner–Mortensen for adults5 (k1¼ 0.99078,
Table 1 | Descriptive statistics with (median (interquartile
range) or percentage) of study populations
CKiD Study
Variable Pilot study Baseline Follow-up
N 27 489 362
Age (years) 14.0 (12.5, 18.0) 11.0 (7.4, 14.4) 12.1 (8.5, 15.6)
Male 56% 64% 65%
Height (m) 1.55 (1.45, 1.66) 1.39 (1.19, 1.57) 1.45 (1.23, 1.62)
Weight (kg) 51.6 (42.7, 74.4) 35.8 (23.4, 53.6) 40.0 (26.1, 56.6)
BSA (m2) 1.50 (1.30, 1.85) 1.18 (0.88, 1.54) 1.26 (0.95, 1.60)
Serum creatinine
(mg/dl)
1.5 (1.1, 2.3) 1.3 (1.0, 1.8) 1.4 (1.0, 2.0)
Iohexol-based GFR
(ml/min per 1.73m2)
51.3 (32.4, 70.0) 43.3 (32.8, 56.0) 42.1 (31.4, 54.3)
BSA, body surface area; CKiD, Chronic Kidney Disease in Children Study
N =27 (Pilot study)
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Figure 1 | Iohexol-based GFR as a function of time of sampling
for the slow curve. GFR for each of the 27 studies of the pilot
study was calculated after 4, 5, and 6 h of sampling. GFR,
glomerular filtration rate.
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k2¼0.001218) and for children7 (k1¼ 1.01, k2¼0.0017)
using 51Cr-EDTA plasma disappearance clearances.
To determine the agreement between GFR4 based on four
points (two for the slow curve at 120 and 300min and two
for the fast curve at 10 and 30min) with the GFR2 obtained
from just the two points in the slow curve (120 and 300min)
and the derived Brochner–Mortensen-like equation, we used
the 362 successful four-point GFR studies performed in
CKiD subjects 1 year later at visit 2. GFR2 was well correlated
(r¼ 0.999) and essentially identical to the four-point GFR4
(Figures 3a, histograms, and b, regression line). As the
regression line of the difference on the mean of the log-
transformed GFR2 and GFR4 had intercept and slope equal
to zero, the Bland–Altman graph in Figure 4 showed that
there was no bias when comparing GFR based on the single
exponential clearance (GFR2) with four-point GFR4, and
that the s.d. of the GFR2 was essentially identical to that
Table 2 |Median (IQR) of plasma disappearance parameters for the 6 h study and the ratios of the 5h and the 4 h to the 6 h
studies (N=27)
Ratios
6 h 5/6 h 4/6 h
Slow curve
Intercept: exp(A) (mg/ml) 0.253 (0.169, 0.318) 1.016 (0.993, 1.035) 1.057** (1.000, 1.092)
Half life: ln(2)/a (min) 172 (148, 297) 0.975 (0.949, 1.009) 0.940** (0.880, 0.996)
Area: exp(A)/a (mg min/ml) 68.1 (41.5, 99.2) 0.999 (0.981, 1.009) 0.991 (0.973, 1.025)
Fast curve
Intercept: exp(B) (mg/ml) 0.172 (0.143, 0.225) 0.983* (0.924, 1.001) 0.983* (0.922, 1.007)
Half life: ln(2)/b (min) 19 (16, 25) 0.970 (0.928, 1.045) 0.926* (0.730, 1.004)
Area: exp(B)/b (mg min/ml) 5.1 (3.5, 6.3) 0.952 (0.882, 1.031) 0.910* (0.695, 1.003)
Total area: slow+fast 74.4 (47.1, 104.3) 0.990 (0.979, 1.005) 0.971** (0.956, 0.995)
Iohexol-based GFR (ml/min per 1.73m2) 51.3 (32.4, 70.0) 1.010 (0.995, 1.021) 1.030** (1.005, 1.043)
GFR, glomerular filtration rate.
*0.01oPo0.05 and **Po0.01 by the sign test relative to the 6 h study.
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Figure 2 |Relationship between GFRs based on the slow
component only (x axis) and the four-point GFR (double
exponential, y axis) in 489 subjects at Visit 1 of the CKiD
study. The regression equation for GFR is given near the bottom
of the graph. CKiD, Chronic Kidney Disease in Children Study; GFR,
glomerular filtration rate.
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Figure 3 |Comparison of GFR2 (based on the slow component
using constants determined from visit 1) to four-point GFR4
studies in visit 2 (N¼ 362) of the CKiD study. (a) Percentile
(2.5th, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 97.5th) box plots
showing a high correlation (r¼ 0.999). (b) Linear regression of
GFR2 on GFR4 showing a very close agreement and a very high
correlation. CKiD, Chronic Kidney Disease in Children Study; GFR,
glomerular filtration rate.
Kidney International (2010) 77, 65–71 67
GJ Schwartz et al.: Optimizing iohexol GFR studies in children with CKD techn i ca l no tes
observed with the four-point GFR4. Furthermore, by the fact
that 95% of differences in Figure 4 were within 5% and
corresponded to only 0.1 of the s.d. of the mean, this is
congruent with a very high correlation (r¼ 0.999).
When GFR2 based on these coefficients for iohexol were
compared with GFR2 using Brochner–Mortensen’s coeffi-
cients for 51Cr-EDTA,7 the agreement along the line of
identity was apparent with a correlation of 40.999 and,
although statistically significant, the GFR values based on the
original formula were downward biased by only 1.4%.
Repeating the development using only two-thirds of the
data from visit one (N¼ 326) with a one-third random
sample (N¼ 163) reserved for validation resulted in identical
inferences. Resampling of the development and validation
sets yielded results from the Bland–Altman analysis of an
average bias of 0.02% and an average ratio of the s.d. of
1.0008 after resampling five times.
DISCUSSION
Choice of iohexol plasma disappearance
In developing clinical and epidemiological studies using GFR
as the primary measure of disease progression, a method that
is reproducible but acceptable to subjects is critical. Retention
is of primary importance in longitudinal studies and can be
affected by challenging or time-consuming protocols. In
preparation for CKiD, we planned to perform formal GFR
measurements in alternate years after the first two study
years, and based on the epidemiology of CKD in children
(with vesicoureteral reflux, bladder dysfunction, etc), con-
ventional renal clearance studies requiring the collection of
urine would be notoriously inaccurate. In view of the fact
that nearly 80% of our recruited subjects had some form of
genito-urinary disease, plasma disappearance technology
would be a preferred method to determine GFR. Obviously,
we chose a non-radioactive marker, because repeated
measurements should not add additional radioactive risk to
the subjects. The choice of iohexol over non-radioactive
iothalamate was based primarily on the finding that
iothalamate is actively secreted by renal proximal tubular
cells8 and its clearance exceeds that of inulin or 51Cr-EDTA;8,9
either agent can be readily measured by high performance
liquid chromatography.10–12 There is abundant data to
suggest that iohexol clearance is quite comparable with
51Cr-EDTA 13,14 and inulin.11,15–17 Indeed, iohexol has been
heralded as the new gold standard measure of GFR.15,18
Duration of plasma disappearance study
A very important component for the proper determination of
the iohexol plasma disappearance curve is the duration of
examination. Empirical studies during renal insufficiency
indicate that a later sampling time is necessary to obtain a
correct determination of GFR;3,19–21 the lower the GFR, the
longer the interval after injection required for plasma
sampling.
Indeed, for single plasma samples and an estimated GFR
of 30ml/min, the optimal sampling time was recommended
to be 8–9 h.19 Stake et al.21 examined plasma clearances in 11
children with chronic kidney failure (mean GFR 12.5ml/min
per 1.73m2) and the effect of the timing of sampling. When
plasma was sampled several times within 3.5 h GFR was
overestimated by more than 50%, compared with the
reference method which obtained samples over 3–24 h. They
recommended that plasma sampling at 3 and 24 h provided
the best interval when clearance was less than 20ml/min per
1.73m2. Similarly, in adult patients with advanced CKD the
most reliable assessment of GFR can be obtained from two
blood samples drawn 5 and 24 h after an intravenous single
injection.22,23 Thus, late plasma sampling is critical for the
accurate determination of GFR by plasma disappearance
methods in patients with renal failure. There are no data on
the timing of sampling for children with mild to moderate
CKD, but for adults with estimated GFR of 15–40ml/min per
1.73m2 it is recommended that two samples be obtained at 6
and 8 h after injection; for GFR above 40ml/min per 1.73m2,
the timing should be at 3 and 4 h.24 Using single injection
iothalamate plasma clearances in men with CKD stages 3 and
4, Agarwal et al.25 found that short plasma sampling intervals
substantially overestimated GFR and reduced precision of the
measurement especially in larger-sized adult patients. Pre-
sumably, the area under the disappearance curve was
underestimated in shorter studies and in bigger adults. In
the group with estimated GFR above 30ml/min per 1.73m2
the two-compartment GFR sampled for a duration of 5 h
overestimated GFR by 17% and sampling for 2 h by 54%,
compared with a 10 h reference. In the group with GFR below
30ml/min per 1.73m2 the magnitude of overestimation was
larger: 5 h sampling was 36% higher and 2 h sampling was
126% higher than the 10 h GFR. The overestimation in
calculated GFR between 4 and 6 h was 9% for estimated
GFR above 30ml/min per 1.73m2 and 21% for estimated
GFR below 30ml/min per 1.73m2. These data need to be
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GFR in the 362 subjects at visit 2 of the CKiD study showing
an insignificant bias of 0.002. The ratio of the s.d. of the GFR2
and the four-point GFR was essentially equal to 1. CKiD, Chronic
Kidney Disease in Children Study; GFR, glomerular filtration rate.
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contrasted for the 3% overestimation we found in the
children (see Figure 1). The mechanism for the over-
estimation observed by Agarwal et al.25 is underestimation
of the area under the curve particularly with the slow phase
of the disappearance curve. Based on the slope of the slow
(renal) curve, Agarwal et al.25 indicate that 5 h sampling
would be adequate for adults with estimated GFRs above
50ml/min per 1.73m2. But for those with an estimated GFR
of 30ml/min per 1.73m2 9 h of sampling would be required.
Whereas the Agarwal study25 attests that the overestima-
tion of GFR is greater in the larger adults, one could interpret
this to mean that the overestimation might be less in
children, who are smaller than adults. Perhaps the smaller
size of the children in this study permitted more rapid
equilibration of the disappearance curves. Indeed, we found
in our 6 h pilot study in children, with median GFR of
51.3ml/min per 1.73m2 that a 5 h study yielded GFR values
practically identical to those at 6 h. The 4 h study over-
estimated GFR by 3%, a significant difference but much
smaller than the differences observed by Agarwal et al.25 in
adult subjects with a median GFR of 37.7ml/min per 1.73m2.
Moreover, when those children with lower GFR values were
examined (see Figure 1), the differences between 4 and 6 h
studies did not appear to be much larger than in those with
higher GFR. Although this overestimation of GFR at 4 h is
statistically significant, in fact it is probably not clinically
important. Therefore termination of plasma disappearance
studies by 4 h in children with moderate CKD but without
edema or obesity should not markedly alter the GFR
measurement. The fact that the mean BMI of the patients
in the Agarwal study25 was high at 32.8 kg/m2 compared with
the value of 24.0 kg/m2 of our pilot study,4 suggests the
possibility that the magnitude of body size or obesity may
adversely influence the attainment of steady-state conditions
and the determination of the area under the curve.
Another possibility to consider in examining the duration
of plasma disappearance is that electro-neutral iohexol may
equilibrate faster than anionic iothalamate, thereby not
requiring as much observation time for calculating GFR.
Although this may only be speculation, other explanations
for why the overestimation of GFR is smaller in children
given iohexol than adults with higher absolute and scaled
GFR given iothalamate are not currently available.
Number of blood sample collections
Another important issue is the timing and the number of
samples required for an accurate measure of iohexol-based
GFR measurement. In considering a longitudinal study with
growth and development, the use of a single sampling point,
with assumptions about the volume of distribution of the
iohexol,15,26,27 seemed too unreliable for regular use,
particularly in growing children of various sizes and muscle
mass. In our previous pilot study4 we initially obtained nine
sampling points from 10 to 360min. But we found that
sampling at four points (10, 30, 120, and 300min) gave
nearly identical results with very high correlation (r¼ 0.999)
and no bias. Reduction to two points would be even more
advantageous, an intravenous line would only need to be
indwelling for 3 h. Moreover, less blood would be taken from
each subject, resulting in less stress and work for the subjects,
nurses, and study coordinators, important considerations in
epidemiological studies. Finally, we hope to use iohexol
disappearance from two finger-prick samples,28 and the
coefficients generated in this article to accurately calculate
GFR, thereby providing a significant epidemiological advan-
tage for future studies.
To further limit the study to two points along the slow
component of the disappearance curve, we needed to develop
a Brochner–Mortensen equation based on the iohexol studies
with four points. The coefficients obtained in this study
were k1¼ 1.0019 and k2¼0.001258, compared with
those generated by Brochner–Mortensen in 30 children by
51Cr-EDTA plasma disappearance,7 which were 1.01 and
0.0017. The agreement with Brochner–Mortensen’s studies,
which used 51Cr-EDTA plasma disappearance, and ours,
which used iohexol, indicates that iohexol is most likely a
reliable marker for GFR that is handled at least comparably
with 51Cr-EDTA. In addition, the similarities of the
coefficients suggest that the distribution and renal excretion
of iohexol are similar to that of 51Cr-EDTA.
It is clear that the one-compartment clearance (slowGFR)
always exceeds true GFR because the area under the curve is
smaller when determined from the one compartment than
from the two or multi-compartment clearance. For low
clearances the differences between one-compartment clear-
ance and GFR are very small, but for higher clearances the
one-compartment model exceeds GFR by 25–30%.5,27 These
observations suggest that a single correction factor would not
be adequate to correlate the one-compartment clearance to
the GFR.27 Brochner–Mortensen5 showed the original quad-
ratic relationship by employing the method of least squares.
We have used a comparable analysis to generate coefficients
in a similar relationship between the one-compartment
slowGFR and the two-compartment (four point) GFR based
on iohexol plasma disappearance.
We have shown here that the combination of the slow
(X120min) GFR and a Brochner–Mortensen like equation
yielded estimates of GFR very close to those obtained from
measurements in both the slow and fast (p60min)
components. This does not imply that the fast area is useless.
Indeed, the slow GFR and the estimate of the two component
GFR via Brochner–Mortensen type equations provide the
basis to estimate the fast area to be linked to variables of
interest for specific scientific aims. However, initiatives which
require not only the fast area but the intercept and slope of
the fast curve would require the collection and analysis of
samples before 60min from the infusion of iohexol, as it was
done in the first two visits of the CKiD study.
It is important to note that the single-compartment
approximation of GFR may not be correctly determined in
patients with large collections of fluids such as ascites, severe
peripheral edema, or pleural effusions, or in severe
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obesity;29,30 examination of the fast disappearance curves
may be important in these situations. There were no
edematous participants in the pilot study and only eight of
the participants in the validation sample of CKiD were noted
to have edema at the time of iohexol measurement. In this
situation the full plasma disappearance curve may need to be
measured, using samples at typically 10, 15, 30, 45, 60, 90,
120, 180, 240, and 300min post injection.4,27 It may be
necessary to sample beyond 300min particularly if the GFR is
reduced. Similarly, it is possible that other characteristics
could contribute to a poor approximation of the two-
compartment GFR using the methods detailed here. How-
ever, the distributions of factors such as BSA, BMI, and age
were equivalent between those with good agreement (within
the 95% LOA) and those with poor agreement (outside the
95% LOA).
In conclusion, GFR can be accurately measured in
children with chronic kidney disease using only the slow
component of the iohexol plasma disappearance curve in
combination with accurate formulas to estimate the two
component-based GFR from the slow GFR, provided the
duration of study is at least 5 h. Based on our analysis of the
demographics of the CKiD population, a single set of
coefficients can be used to accurately compute GFR from
the slow (renal) iohexol plasma disappearance curve.
MATERIALS AND METHODS
Study participants
The pilot study included 27 children.6 There were 12 with
obstructive uropathy-dysplasia, four with kidney transplants, four
with chronic glomerulonephritis, and seven with other diseases
(including hereditary and cystic kidney disease).
For the CKiD study, eligible subjects were 1–16 years of age with
mild to moderate CKD, based on GFR estimates by the original
Schwartz formula31–33 in the 30–90ml/min per 1.73m2 range.
Subjects from 46 local sites were recruited. At the study visit,
demographics, height, weight, and vital signs were determined. Body
surface area (BSA) was determined using the formula of Haycock
et al.34 A total of 570 children were enrolled in the study by February
2009 of whom 62% were male, 70% Caucasian, 21% African
American, and 15% were of Hispanic ethnicity; 21% had glomerular
disease. At enrollment, 50% of the cohort had age below 11 years,
duration of CKD above 6.5 years, enzymatic serum creatinine above
1.3mg/dl, cystatin C above 1.75mg/l, urine protein:creatinine ratio
above 0.5, and iohexol-based GFR below 44ml/min per m2.
Both the pilot study and the CKiD study were approved by
Research Review Boards at all participating sites in the United States
and Canada.
Effect of time span of iohexol plasma disappearance studies
An intravenous line or butterfly needle was used to administer 5ml
of iohexol and was removed following the injection. A second
intravenous line was saline locked and used for obtaining blood
samples. Blood samples (1ml) for the pilot study were obtained at
10, 20, 30, 60, 120, 180, 240, 300, and 360min after the iohexol
injection.4
The plasma disappearance curve can be partitioned into two
exponential decay curves and parameters for the two curves
obtained by the technique of curve stripping. Specifically, as the
contribution of the fast component is negligible after 120min,
fitting the line log(iohexol concentration)¼Aa time for times
past 120min yields the slow curve with expected concentration at
time zero (¼ exp(A)) and the slope (¼ a). When the values along
the slow curve (¼ exp(Aa time)) are subtracted from the
concentrations observed within the first 2 h, a second linear
function (fast curve) by fitting log(concentrationexp
(Aa time))¼Bb time is obtained. The area under the sum
of the two (slow and fast) curves is given by exp(A)/aþ exp(B)/b.
The plasma clearance of the substance, taken as GFR calibrated to a
body surface area of 1.73m2, can be calculated as:1
GFR ¼ fDose=½ðexpðAÞ=aÞ þ ðexpðBÞ=bÞgf1:73=BSAg;
where dose is the administered amount of iohexol in mg
(mean¼ 3200mg). To determine the possible bias because of
shortening the time span of iohexol plasma disappearance studies,
we calculated the medians of ratios between studies of 5 and 6 h and
between studies of 4 and 6 h. Statistical significance for whether the
median ratio was 1 was determined by the signed rank test.
Agreement between one-compartment and
two-compartment GFR measures
At the baseline and first annual follow up visits of the CKiD study,
the protocol for the determination of GFR from disappearance
curves of iohexol specified the collection of sera at 10, 30, 120, and
300min after infusion of iohexol. As the GFR is based on four time
points, we refer to it hereafter as GFR4. Of the 570 CKiD children
with an initial study visit by February 2009, 489 (86%) had a
successful GFR4. Sera in serum separator tubes were shipped at
room temperature to the Central Biochemistry Laboratory based in
Rochester, NY. Iohexol is stable at room temperature for more than
1 week (GJ Schwartz, B Erway, and T Kwong, unpublished
observations). Iohexol concentration in mcg/ml was determined in
deproteinated sera by HPLC as previously described.4 The methods
to determine the intercepts and slopes of the slow (A and a) and fast
(B and b) components were the same as those indicated above for
the nine-point protocol of the pilot study.4
The data from the visit 1 iohexol studies which rendered GFR
based on the four time points were used to derive a Brochner–-
Mortensen-like equation5 relating the GFR based on the two-
compartment disappearance curves (slow and fast) to the GFR
using simply the slow component, slowGFR, defined as
slowGFR¼ {Dose/[exp (A)/a]} {1.73/BSA}. Specifically, we used
standard polynomial regression methods to fit the equation
k1 slowGFRþ k2 (slowGFR)2 to the measured GFR4.
Using the estimates of the coefficients k1 and k2 obtained from
the 489 data points from the baseline visit, the definitive comparison
between the GFR determined from four points (GFR4) and that
based on two points with the CKiD-based Brochner–Mortensen
equation (GFR2) was accomplished by examining the test set of 362
children who completed a successful visit 2 with GFR measured
using four time points. The agreement was assessed by extending the
methods proposed by Bland and Altman.35 Results from the
validation using visit 2 data were compared with those from a
development and validation done solely in visit 1 using a 2/31/3
data split. Resampling of the development and validation data sets
was done five times.
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